What is Aimedis (AIMx)
Aimedis is a Netherlands and UAE based company providing an innovative next-generation healthcare solution designed to connect patients to healthcare services and providers like doctors, hospitals and scientific research facilities.
While competitors exist in this space, Aimedis is one of the few companies with an operational platform to integrate latest blockchain technology alongside artificial intelligence (AI).
Aimedis is the only existing medical ecosystem combining professional healthcare knowledge with the swarm intelligence of patient communities. The Aimedis team has been working on multiple e-health projects since 2009 including a solution for the pharmaceutical industry. Our experiences combined with more than 12 years of clinical experience and experience in the pharmaceutical industry of the founders are integral components of the ecosystem. An ecosystem, which benefits both the patients and professionals in the medical field.
Pre-sales: Jun 01, 2021 – Sep 17, 2021
Public sales: Sep 18, 2021 – Oct 01, 2021
IEO (Probit Launchpad): Nov 26, 2021 – Dec 05, 2021
Pre-sale token supply: 56,000,000 AIMx
Token supply: 600,000,000 AIMx
Total tokens for sale: 60,000,000 AIMx
Soft cap: 1,000,000 USD
Hard cap: 2,200,000 USD
Raised: 1,300,000 USD
Blockchain Platform: Binance Smart Chain
Office address: Sint Michaëlstraat 4, 5935 BL Steyl, Netherlands
Country limitations: China, Singapore, United States
Registration country: Netherlands
Token standard: BEP-20
Dividends: 12,5% APY if staking a minimum of 200.000 AIMx for at least 6 months.
Token price in USD: 1 AIMx = 0.05 USD
Accepted currencies: USDT, USDC, ETH, BTC
Ecosystem Incentives – 30%
Staking Rewards – 20%
Treasury – 20%
Aimedis Foundation – 10%
Team & Advisors – 10%
Private & Public Sale – 10%